ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 128 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,672,000 | -40.6% | 370,000 | 0.0% | 2.70% | -26.5% |
| Q2 2018 | $9,550,000 | +8.1% | 370,000 | 0.0% | 3.67% | +6.4% |
| Q1 2018 | $8,832,000 | -17.2% | 370,000 | +17.5% | 3.44% | -8.4% |
| Q4 2017 | $10,669,000 | +29.3% | 315,000 | -19.2% | 3.76% | +17.1% |
| Q3 2017 | $8,252,000 | +155.0% | 390,000 | +110.5% | 3.21% | +161.1% |
| Q2 2017 | $3,236,000 | 0.0% | 185,234 | 0.0% | 1.23% | -0.7% |
| Q1 2017 | $3,236,000 | +3.4% | 185,234 | 0.0% | 1.24% | -12.1% |
| Q4 2016 | $3,130,000 | – | 185,234 | – | 1.41% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
| AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
| Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
| Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
| Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
| DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
| Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |